Ruthenacarborane-Phenanthroline Derivatives as Potential Metallodrugs.

Ruthenium-based complexes have received much interest as potential metallodrugs. In this work, four Ru complexes bearing a dicarbollide moiety, a carbonyl ligand, and a phenanthroline-based ligand were synthesized and characterized, including single crystal diffraction analysis of compounds , , and and an observed side product . Complexes - are air and moisture stable under ambient conditions.

Heteropolytopic arsanylarylthiolato ligands: cis-trans isomerism of nickel(II), palladium(II), and platinum(II) complexes of 1-AsPh2-2-SHC6H4.

Heteropolytopic arsanylthiolato ligands 1-AsPh(2)-2-SHC(6)H(4) (AsSH), PhAs(2-SHC(6)H(4))(2) (AsS(2)H(2)), and As(2-SHC(6)H(4))(3) (AsS(3)H(3)) have been prepared by lithiation-electrophilic substitution procedures. The 2:1 reaction of AsSH with NiCl(2)·6H(2)O, Na(2)[PdCl(4)], and [PtI(2)(cod)] (cod = 1,5-cyclooctadiene) in the presence of NEt(3) afforded the square-planar complexes trans-[Ni{(AsS)-κ(2)S,As}(2)] (1), cis-[Pd{(AsS)-κ(2)S,As}(2)] (2), trans-[Pd{(AsS)-κ(2)S,As}(2)] (3), and cis-[Pt{(AsS)-κ(2)S,As}(2)] (4). In the cases of nickel and platinum, only one isomer was isolated.

Heteropolytopic phosphanylarylthiolato ligands: formation of cis isomers of nickel(II), palladium(III) and platinum(III) complexes with 1-P(Biph)-2-SHC6H4 (Biph = 1,1'-biphenyl-2,2'-diyl).

Reaction of the ditopic phosphanylarylthiol 1-P(Biph)-2-SHC(6)H(4) (BiphPSH, Biph = 1,1'-biphenyl-2,2'-diyl), prepared by lithiation-electrophilic substitution, with NiCl(2)·6H(2)O, Na(2)[PdCl(4)] and [PtI(2)(cod)] (cod = 1,5-cyclooctadiene) in a 2:1 ratio and in the presence of NEt(3) led to formation of exclusively cis isomers of the square-planar complexes cis-[M{(1-P(Biph)-2-S-C(6)H(4))-κ(2)S,P}(2)] ([M{(BiphPS)-κ(2)S,P}(2)]; M = Ni (1), Pd (2), Pt (3)). Density functional calculations support the assumption that this is probably due to intramolecular π-π interaction of the biphenyl groups, which results in enhanced stability of the cis isomers. Compound 1 is the first example of a structurally characterised mononuclear cis-bis(phosphanylthiolato)nickel(III) complex.

Reaction of a heterotopic P,SAs ligand with group 10 metal(II) complexes: As-S bond cleavage and the formation of two unusual trinuclear structural isomers for Pd and Pt.

The synthesis of the heterotopic P,SAs ligand, 1-Ph(2)AsSC(6)H(4)-2-PPh(2) (1) and its reaction with [PdCl(2)(cod)], [PtI(2)(cod)] (cod = 1,5-cyclooctadiene) and NiCl(2)·6H(2)O is reported. Cleavage of the As-S bond of 1 and coordination of the resulting phosphanylthiolato ligand (SC(6)H(4)-2-PPh(2))(-) (SC(6)H(4)-2-PPh(2) = P,S) was observed with formation of [M(P,S)(2)] (M = Ni, Pd, Pt). In the case of Pd and Pt, not only the mononuclear complexes [M(P,S)(2)] formed, but also the trimers of [MX(P,S)] ([MX{(μ-S-SC(6)H(4)-2-PPh(2))-κ(2)S,P}](3) [M = Pd, X = Cl (2) and M = Pt, X = I (4)]).

A comparability study of 5 commercial KRAS tests.

Background: Activating mutations in the KRAS gene occur frequently in human tumors, including colorectal carcinomas; most mutations occur in codons 12 and 13. Mutations in KRAS have been associated with poor response to anti-epidermal growth factor receptor antibodies. Therefore, an accurate and readily available analysis of KRAS mutational status is needed.